Eric G. Carter

Long-Term Safety and Efficacy of Alosetron in Women with Severe Diarrhea-Predominant Irritable Bowel Syndrome

William D. Chey, William Y. Chey, Amy Heath et al. · The American Journal of Gastroenterology · 2004 · 146 citations

A Dose-Ranging, Phase II Study of the Efficacy and Safety of Alosetron in Men with Diarrhea-Predominant IBS

Lin Chang, Vanessa Z. Ameen, George E. Dukes et al. · The American Journal of Gastroenterology · 2005 · 140 citations

A Randomized, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of 0.5 mg and 1 mg Alosetron in Women With Severe Diarrhea-predominant IBS

Richard A. Krause, Vanessa Z. Ameen, Susan Gordon et al. · The American Journal of Gastroenterology · 2007 · 118 citations

Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: Analysis of two controlled trials

Anthony Lembo, Kevin W. Olden, Vanessa Z. Ameen et al. · Clinical Gastroenterology and Hepatology · 2004 · 68 citations

Food Intolerance, Functional Gastrointestinal Disorder, Bowel Urgency +5

Ranitidine (Zantac??) Syrup versus Ranitidine Effervescent Tablets (Zantac?? EFFERdose??) in Children

Vanessa Z. Ameen, Bonnie Pobiner, Gregory C. Giguere et al. · Pediatric Drugs · 2006 · 26 citations

Drug Safety, Medicine, Pediatrics +4